Health Care/Hospital

J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- J INTS BIO provided an update of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, during the 3rd of June poster session of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held at Mc...

2024-06-10 13:56 1657

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), today announced initiation of its Early Feasibility Study (EFS) for the HyperQure™ system following FDA IDE ap...

2024-06-10 13:14 1618

Dontia Alliance introduced its first Advanced Implant Strategies Centre of Excellence in Malaysia and four (4) other centres are in the pipeline

* The first AIS Centre was launched in Penang, Malaysia on 8 June 2024 *  Four (4) more AIS Centres are slated to be launched in Singapore, Hong Kong (SAR), Vietnam and the Philippines in the next two years SINGAPORE, June 10, 2024 /PRNewswire/ -- Dontia Alliance Pte. Ltd. ("DA") introduced its...

2024-06-10 10:00 2798

United Imaging Prepares to Ship its 30,000th Unit Globally, a uMI Panorama GS, from Houston for U.S. Installation

The uMI Panorama GS is among the all-digital Molecular Imaging systems United Imaging is featuring at SNMMI in Toronto SHANGHAI, June 8, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, is on the brink of a significant milestone as it a...

2024-06-08 21:00 4028

ILJIN SNT Co., Ltd. Announces Its Intention to Vote Against Aurinia Pharmaceuticals's Revised Equity Incentive Plan Proposal

SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Dear Fellow Shareholders, ILJIN SNT Co., Ltd. ("ILJIN") is a long-standing investor of Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company"), and, together with its affiliates, currently holds more than 5% of Aurinia's common stock. As one of...

2024-06-07 23:49 5705

deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans

A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate and nature of mutations in mitochondrial DNA (mtDNA) and the peculiar dynamics of its maternal transmission REYKJAVIK, Iceland, June 7, 2024 /PRNewswire/ -- In a paper published toda...

2024-06-07 23:00 2742

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

BEIJING and PARIS, June 7, 2024 /PRNewswire/ -- Tsingke successfully wrapped up its debut at TIDES USA 2024, the premier event for oligonucleotides, peptides, mRNA, and genome editing. Held fromMay 14-17 at the Hynes Convention Center in Boston, the conference brought ...

2024-06-07 22:09 4217

Amorepacific Hosts NBRI Symposium

Announces Results of Skin Aging Research Conducted in collaboration with The Johns Hopkins University School of Medicine SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Amorepacific hosted the "New Beauty Research Initiative (NBRI) Symposium" at its R&I Center in Yongin, Korea, onWednesday, Jun...

2024-06-07 21:00 3969

THRIVING BEYOND CANCER: Pantai Hospital Kuala Lumpur's Heartfelt Month of Celebration and Support to Cancer Survivors with Special June Activities

KUALA LUMPUR, Malaysia, June 7, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL), a beacon of medical excellence and compassionate patient care, proudly announces a series of events in celebration ofCancer Survivor Month. These activities underscore PHKL's unwavering commitment to support...

2024-06-07 20:50 4618

IONETIX Produces First Batch of Actinium-225

LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of Actinium-225 ("Ac-225") at its isotope manufacturing facility located inLansing, Michigan. This fir...

2024-06-07 20:27 1838

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024

New translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection BRII-179 as add-on therapy induces functional antibody responses and contributes toimproved sustained HBsAg loss in PEG-IFNa-t...

2024-06-07 19:00 2430

Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma

SINGAPORE, June 7, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced that clinical data from its first-in-class autologous hepatitis B virus (HBV)-specific...

2024-06-07 16:51 2449

3 Major Product Releases at 3Shape Discover Event

* TRIOS Core - New TRIOS intraoral scanner system for just $12,400 * Remodeled TRIOS 3 intraoral scanner - the classic gets new look * TRIOS Ready Tips - single-use intraoral scanner tips for TRIOS 5 COPENHAGEN, Denmark, June 7, 2024 /PRNewswire/ -- 3Shape announces the launch of three excit...

2024-06-07 15:39 576

MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease

TAINAN, June 7, 2024 /PRNewswire/ -- MLB (Merry Life Biomedical Company, Ltd., Taiwan: https://www.tmlbio.com/ ), a biomedical company, announced that the U.S. Food and Drug Administration (FDA) has approved IND application forTML-6, an novel drug to treat Alzheimer's dis...

2024-06-07 15:00 2132

Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024

JINAN, China, June 6, 2024 /PRNewswire/ -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened fromMay 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works, three clinical studies from Qilu Pharmaceutical were selected for poster sessio...

2024-06-07 14:51 1586

Potential Add-on Treatment for Patients with Parkinson's Disease: Stimvia Completes Pilot Study and Announces Promising Initial Results

PRAGUE, June 7, 2024 /PRNewswire/ -- Stimvia , a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson's Disease (PD) and is expecting promising results.   ...

2024-06-07 07:00 2562

Big Tree Cloud and Plutonian Announce Closing of Business Combination

Big Tree Cloud's shares and warrants are expected to begin trading on Nasdaq under the tickers "DSY" and "DSYWW", respectively, onJune 7, 2024 SHENZHEN, China, June 6, 2024 /PRNewswire/ -- Big Tree Cloud International Group Limited ("Big Tree Cloud" or the "Company"), a company devoted to the de...

2024-06-07 04:15 2141

IMG Expands Partnership with Teladoc Health to Provide More Travelers with Telehealth Services

INDIANAPOLIS, June 6, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, has announced an expansion of their partnership with Teladoc Health, the global leader in whole person virtual care. Service capabilities will ...

2024-06-06 21:00 2047

Databricks Doubles Down on Delta Sharing Open Ecosystem With Product Innovations and Strategic Partnerships

New and Expanded Partnerships Span Industries, Including Financial Services, Healthcare and Life Sciences, Marketing and Advertising, and More to Enable Cross-Platform Collaboration New Marketplace Listings Feature Data, AI Models, and Solution Accelerators SAN FRANCISCO, June 6, 2024 /PRNewswir...

2024-06-06 21:00 2281

Xiao-I Partners with Global Leader in Health Technology to Enhance Knowledge Management with AI Solutions

SHANGHAI, June 6, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading AI company, announces a contract is secured from a renowned multinational conglomerate in the health technology sector base inChina. This contract is set to revolutionize knowledge mana...

2024-06-06 20:01 4051
1 ... 75767778798081 ... 847

Week's Top Stories